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Abstract 
Chronic renal disease is associated with advanced age, diabetes, hypertension, 
obesity, musculoskeletal problems and cardiovascular disease, the latter being the 
main cause of mortality in patients receiving haemodialysis (HD). Cooled dialysate 
(35 °C-36 °C) is recently employed to reduce the incidence of intradialytic 
hypotension in patients on chronic HD. The studies to date that have evaluated 
cooled dialysate are limited, however, data suggest that cooled dialysate improves 
hemodynamic tolerability of dialysis, minimizes hypotension and exerts a protective 
effect over major organs including the heart and brain. The current evidence-based 
review is dealing with the protective effect of cold dialysis and the benefits of it in 
aspects affecting patients’ quality of care and life. There is evidence to suggest that 
cold dialysis can reduce cardiovascular mortality. However, large multicentre 
randomized clinical trials are urgently needed to provide further supporting 
evidence in order to incorporate cold dialysis in routine clinical practice. 
 
Key words: Mortality; Cardiovascular diseases; Fatigue; Hypotension; Shivering; 
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Core tip: Cooled dialysate (35 °C-36 °C) is recently employed to reduce the incidence 
of intradialytic hypotension in patients on chronic haemodialysis. The studies to 
date that have evaluated cooled dialysate are limited, however, data suggest that 
cooled dialysate improves hemodynamic tolerability of dialysis and exerts a 
protective effect over major organs. There is evidence to suggest that cold dialysis 
can reduce cardiovascular mortality and improve patients’ levels of post-dialysis 
fatigue further improving general health and quality of life.  
 
Sakkas GK, Krase AA, Giannaki CD, Karatzaferi C. Cold dialysis and its impact on 
renal patients’ health: An evidence-based mini review. World J Nephrol 2017; In press 
INTRODUCTION 
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Chronic renal disease is nowadays recognised as a worldwide public health 
problem[1] while cardiovascular diseases are the main cause of mortality in end-stage 
renal patients receiving haemodialysis (HD) therapy[2]. HD per se is associated with 
cardiovascular and haemodynamic stress that could lead to recurrent and 
cumulative ischemic events to vital organs such as the brain and the myocardium. 
This stress is associated with perfusion abnormalities leading to myocardial 
hypoperfusion and myocardial stunning during HD sessions[3].  
One of the most common HD complications, affecting 20%-30% of chronic HD 
patients, is intradialytic hypotension (IDH) which significantly impacts patients’ 
quality of life and overall health[4]. Moreover, hypotensive episodes, together with 
the commonly experienced post-dialysis fatigue as well as myopathy and 
arrhythmias, contribute to an increased risk for falls and long lasting disabilities[5]. It 
seems that one of the most effective, inexpensive and low risk interventions to 
improve haemodynamic stability during HD therapy is to lower the dialysate 
temperature by one or two degrees Celsius[6,7]. This is called “cold” dialysis and it is 
gradually becoming a popular way of managing HD side effects to prevent IDH and 
post dialysis fatigue.  
 
WHAT IS COLD DIALYSIS? 
The dialysate temperature is traditionally set to 37 °C as a means of keeping stable 
the HD patient’s body core temperature and maintain isothermia (between 36.5 °C-
36.9 °C). In reality however, the “warm dialysis” does not maintain isothermia but 
induce a mild hyperthermic effect which on average, rise the core temperature by 
approximately	   0.5°-0.7° Celsius[8], which contributes further to high incidence of 
hypotensive episodes (as eloquently discussed in Pizzarelli 2007[7]). In “cold” 
dialysis the temperature of the dialysate is set at least one degree below the standard 
dialysate temperature, with the majority of the cold dialysis studies using dialysate 
temperatures between 35 °C-36 °C[9,10]. A better approach would be to personalise the 
dialysate temperature for each patient (for example by using the changes in body 
core temperature or 0.5 °C below resting body core temperature). An attempt to offer 
personalised isothermic HD throughout the session may be an even better approach; 
however this is quite difficult to achieve (for example due to eating habits of patients 
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or other internal or external variations)[7]. In the clinical setting, most of the times, 
the temperature is set one degree below the standard clinical practice and guided by 
the patients comfort levels[10].  
The use of cold dialysis started in 1980s as an attempt to control the burden of 
IDH[11,12]. Since then, the extracorporeal cooling of blood on dialysis has been 
employed as a countermeasure to reduce episodes of IDH, however many other 
benefits have been observed on patients’ overall health and quality of life levels[13]. 
 
BENEFITS OF COLD DIALYSIS  
The benefits of the cold dialysis in patients’ health are based on the fact that 
lowering the body core temperature will improve systemic vascular resistance and 
therefore improve haemodynamic stability[14]. Other reasons speculated for the 
observed benefits are the avoidance of heat accumulation and hence 
counterproductive thermoregulatory vasodilation, and the catecholamine surge 
(especially during shivering) which in turn stimulate peripheral vasoconstriction 
and cardiac inotropy[12,13]. In particular, even with modest heat storage, profound 
haemodynamic changes take place, including a reduction in peripheral vascular 
resistances, elevated heart rate, cardiac output and increased muscle sympathetic 
nerve activity, resulting in increased blood flow to the skin and leaving the body 
defenceless to hypotension[15], a phenomenon that does not take place during cold 
stress. It should be noted, that at least in healthy subjects, the response to heat 
accumulation will occur even in the face of a “hypovolaemic stress”[16], a further 
consideration in HD patients. 
 
Intradialytic hypotension 
IDH is an independent risk factor for cardiovascular mortality in HD patients[17] and 
significantly affects patients post dialysis energy levels and overall quality of life[18]. 
Many therapeutic interventions have been applied in order to reduce IDH, however, 
a single approach that would successfully prevent or solve this issue doesn’t yet 
appear to exist. Cold dialysis is a very promising approach for the prevention of IDH 
with many studies reporting improvements in haemodynamic stability including 
reduction in heart rate, cardiac output and stroke volume leading to high arterial 
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blood pressure maintaining thus a greater total peripheral resistance[6,15]. A study 
has shown that IDH occurred 7.1 times less frequently with cold dialysis while the 
post-dialysis mean arterial pressure was higher with cool-temperature dialysis by 
11.3 mmHg[14]. In addition, cold dialysis resulted in significantly fewer nursing trips 
to patient’s bed and even fewer interventions for the treatment of IDH, positively 
influencing the functionality of the HD unit[19] and the level of overall care.  
 
Cardiovascular and cerebrovascular risk 
HD patients are at high risk of cardiovascular mortality which has been reported as 
15%-20%[20] and 38%[2] of all cause deaths. The causes of the high cardiovascular 
mortality are multifactorial including traditional (diabetes, hypertension) and non-
traditional (uremic-related), however, the HD per se is a very strong contributor into 
the overall mortality affecting myocardial functionality (e.g., myocardial stunning 
and hibernation) and morphology[21]. Benefits of the long term cold dialysis (1 year) 
have been reported in the recent literature in both brain and heart tissues. In the 
brain, cold dialysis seems to induce a protective effect from injurious perfusion of 
the cerebral vascular beds, thus minimizing HD induced brain injuries[9]. In the 
heart, after a long term induction of cold dialysis (0.5 °C below body core 
temperature) positive changes in resting ejection fraction were observed 
accompanied with significant reductions in both left ventricular mass and left 
ventricular end-diastolic volumes while the aortic distensibility was preserved, thus 
minimizing the risk for future cardiovascular events[22]. 
 
Dialysis efficiency 
Due to the vasoconstriction effect induced by the cold dialysis, it was postulated that 
dialysis efficiency indices would be reduced as a result of the increased 
compartmentalization of urea and the post-dialysis increased rebound effect[23]. 
Many studies including two systematic reviews concluded that cold dialysis do not 
change blood volume, urea rebound or effective Kt/V index leaving dialysis 
efficiency unchanged[6,14] while one study showed significant improvements in urea 
removal and Kt/V[24].  
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Patients perception 
In general, HD patients tolerate long term cold dialysis very well, reporting high 
levels of satisfaction (76%-80%), less fatigue, faster recovery times after dialysis, 
feeling more energetic, with better cognitive capacity and having the overall 
sensation that their general health has dramatically improved (Table 1)[14,24,25]. Most 
authors reported that at the end of the trial period, a large number of patients 
requested to always be dialysed with a cooler dialysate[13]. It seems that cold dialysis 
has also a positive impact in dialysis units’ functionality since many studies have 
reported a reduced number of nursing interventions during HD and less in-patient 
admissions for treating post-dialysis hypotensive symptoms[13]. The most commonly 
reported cold dialysis side effects are related to cold sensation with 20% of the 
patients reporting to be feeling cold[13] while some studies have also reported 
incidences of shivering[25]. No other serious disadvantages of cold dialysis have been 
reported in the recent literature, however, the lack of long term interventions and 
properly designed randomized clinical trials justifies the modest implementation of 
cold dialysis in the majority of the dialysis units worldwide. 
 
CONCLUSIONS AND RECOMMENDATIONS  
Lowering the dialysate temperature in HD patients’ routine therapies can reduce the 
rate of intradialytic hypotension by increasing peripheral resistance leading to 
increased intradialytic mean arterial pressure without jeopardising dialysis 
adequacy. There is evidence to suggest that cold dialysis can reduce cardiovascular 
mortality and improve patients’ levels of post-dialysis fatigue further improving 
general health and quality of life. Large, multicentre, randomized clinical trials are 
urgently needed to provide further supporting evidence on aspects related to 
mortality and major adverse cardiovascular events. 
 
KEY POINTS 
Cold dialysis is achieved by lowering the dialysate temperature to 35 °C-36 °C or 0.5 
°C below resting body core temperature. Cold dialysis can be implemented with no 
additional cost and is universally applicable. Cold dialysis reduces incidence of 
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intradialytic hypotension and improve patients’ “energy” levels. Cold dialysis could 
induce some general discomfort to the patients  
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Table 1 Pros and cons implementing “cold dialysis” 
Measurable and perceived benefits Measurable and perceived side effects 
Reduce intradialytic hypotension 
incidences 
Possible patient discomfort (shivering) 
Induce hemodynamic stability   
Reduce ischemic brain injuries and 
preserving brain’s white matter  
 
Improve cardiac functionality and 
morphology indices 
 
  
Control arterial blood pressure during 
and after haemodialysis  
 
Reduce post-dialysis fatigue  
Increase energy levels  
Dialysis efficiency is not changed   
  
Improve overall perception of general 
health 
 
Reduce the number of nursing 
interventions during HD 
 
Can be delivered without additional 
cost and is universally applicable 
 
 
HD: Haemodialysis. 
